Biotech

All Articles

A nearer take a look at Fierce Biotech's Tough 15

.In this particular full week's incident of "The Leading Pipe," our experts're diving into Brutal Bi...

Lilly experiences phase 2 failing of tau-targeting med

.The confetti is actually still flying from Eli Lilly's gathering commemorating the approval of Alzh...

Biogen CMO Maha Radhakrishnan joins Sofinnova-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of substantial leadership hirings, firings a...

Lykos will definitely inquire FDA to reevaluate its selection adhering to rejection of MDMA therapy for post-traumatic stress disorder

.Adhering to an unsatisfactory revealing for Lykos Therapeutics' MDMA applicant for post-traumatic s...

AN 2 one-halfs census, quits phase 3 trial after records disappoint

.AN2 Therapeutics is reassessing its own service in response to poor midphase information, promising...

Merck pays out $700M for bispecific, spying autoimmune position as well as chance to challenge Amgen in cancer

.Merck &amp Co. is actually paying for $700 million upfront to test Amgen in a blood stream cancer c...

Gilead pays for J&ampJ $320M to exit licensing offer for seladelpar

.With Gilead Sciences almost an FDA decision for its liver disease medicine seladelpar, the provider...

' All hands on deck' at Lilly as peers target weight problems market

.CEO David Ricks may see the firms setting up outdoors tents at basecamp responsible for Eli Lilly i...

Entero laying off team, leaving workplace and also stopping briefly R&ampD

.Bed Liquidators has actually switched Entero Therapies white colored as a slab. The creditor bought...

Exelixis goes down ADC after determining it is actually no match for Tivdak

.Exelixis is actually losing hope on its tissue factor (TF)- targeting antibody-drug conjugate after...